UBS Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.9K | Buy |
8,405
+6,284
| +296% | +$35.1K | ﹤0.01% | 7503 |
|
|
2025
Q4 | $14.2K | Buy |
2,121
+793
| +60% | +$4.7K | ﹤0.01% | 8019 |
|
|
2025
Q3 | $5.83K | Sell |
1,328
-77,893
| -98% | -$370K | ﹤0.01% | 8826 |
|
|
2025
Q2 | $352K | Buy |
79,221
+76,864
| +3,261% | +$321K | ﹤0.01% | 6312 |
|
|
2025
Q1 | $13.3K | Sell |
2,357
-1,360
| -37% | -$17.4K | ﹤0.01% | 8465 |
|
|
2024
Q4 | $78.4K | Buy |
3,717
+1,645
| +79% | +$37.8K | ﹤0.01% | 7028 |
|
|
2024
Q3 | $55.7K | Buy |
2,072
+686
| +49% | +$20.2K | ﹤0.01% | 6748 |
|
|
2024
Q2 | $39.5K | Sell |
1,386
-2,687
| -66% | -$94.3K | ﹤0.01% | 6868 |
|
|
2024
Q1 | $173K | Sell |
4,073
-584
| -13% | -$26.3K | ﹤0.01% | 5950 |
|
|
2023
Q4 | $249K | Buy |
4,657
+2,630
| +130% | +$119K | ﹤0.01% | 5631 |
|
|
2023
Q3 | $87.2K | Sell |
2,027
-662
| -25% | -$30.5K | ﹤0.01% | 5920 |
|
|
2023
Q2 | $148K | Buy |
2,689
+2,337
| +664% | +$128K | ﹤0.01% | 5699 |
|
|
2023
Q1 | $14.8K | Sell |
352
-135
| -28% | -$4K | ﹤0.01% | 7321 |
|
|
2022
Q4 | $13.5K | Buy |
487
+208
| +75% | +$5.13K | ﹤0.01% | 8164 |
|
|
2022
Q3 | $7K | Buy |
279
+217
| +350% | +$7.18K | ﹤0.01% | 8872 |
|
|
2022
Q2 | $2K | Sell |
62
-248
| -80% | -$11.2K | ﹤0.01% | 9559 |
|
|
2022
Q1 | $19K | Sell |
310
-762
| -71% | -$45.1K | ﹤0.01% | 7508 |
|
|
2021
Q4 | $75K | Buy |
1,072
+749
| +232% | +$53.3K | ﹤0.01% | 6550 |
|
|
2021
Q3 | $23K | Buy |
323
+287
| +797% | +$22.8K | ﹤0.01% | 7014 |
|
|
2021
Q2 | $3K | Sell |
36
-527
| -94% | -$37.3K | ﹤0.01% | 8807 |
|
|
2021
Q1 | $31K | Sell |
563
-332
| -37% | -$16.1K | ﹤0.01% | 6982 |
|
|
2020
Q4 | $38K | Buy |
895
+789
| +744% | +$29.4K | ﹤0.01% | 6420 |
|
|
2020
Q3 | $3K | Sell |
106
-1,138
| -91% | -$38.3K | ﹤0.01% | 7532 |
|
|
2020
Q2 | $39K | Buy |
1,244
+1,238
| +20,633% | +$33.4K | ﹤0.01% | 6081 |
|
|
2020
Q1 | $0 | Sell |
6
-296
| -98% | -$8.02K | ﹤0.01% | 8126 |
|
|
2019
Q4 | $9K | Sell |
302
-57
| -16% | -$1.64K | ﹤0.01% | 7333 |
|
|
2019
Q3 | $11K | Sell |
359
-108
| -23% | -$2.68K | ﹤0.01% | 7100 |
|
|
2019
Q2 | $9K | Buy |
467
+367
| +367% | +$10.8K | ﹤0.01% | 7126 |
|
|
2019
Q1 | $4K | Sell |
100
-1,374
| -93% | -$49.8K | ﹤0.01% | 7253 |
|
|
2018
Q4 | $47K | Sell |
1,474
-129
| -8% | -$5.08K | ﹤0.01% | 6139 |
|
|
2018
Q3 | $85K | Buy |
1,603
+944
| +143% | +$53K | ﹤0.01% | 5723 |
|
|
2018
Q2 | $36K | Buy |
659
+584
| +779% | +$29.9K | ﹤0.01% | 6253 |
|
|
2018
Q1 | $4K | Sell |
75
-107
| -59% | -$4.8K | ﹤0.01% | 7324 |
|
|
2017
Q4 | $6K | Buy |
182
+1
| +0.6% | +$34 | ﹤0.01% | 7299 |
|
|
2017
Q3 | $7K | Sell |
181
-186
| -51% | -$5.5K | ﹤0.01% | 7067 |
|
|
2017
Q2 | $9K | Sell |
367
-54
| -13% | -$1.34K | ﹤0.01% | 6841 |
|
|
2017
Q1 | $11K | Sell |
421
-55
| -12% | -$1.58K | ﹤0.01% | 6552 |
|
|
2016
Q4 | $14K | Sell |
476
-227
| -32% | -$5.77K | ﹤0.01% | 6722 |
|
|
2016
Q3 | $19K | Buy |
703
+291
| +71% | +$8.08K | ﹤0.01% | 6329 |
|
|
2016
Q2 | $12K | Buy |
412
+227
| +123% | +$7.22K | ﹤0.01% | 6674 |
|
|
2016
Q1 | $6K | Sell |
185
-447
| -71% | -$12.7K | ﹤0.01% | 6920 |
|
|
2015
Q4 | $22K | Buy |
632
+457
| +261% | +$15.6K | ﹤0.01% | 6652 |
|
|
2015
Q3 | $7K | Hold |
175
| – | – | ﹤0.01% | 7499 |
|
|
2015
Q2 | $10K | Sell |
175
-26
| -13% | -$1.48K | ﹤0.01% | 7454 |
|
|
2015
Q1 | $12K | Buy |
201
+6
| +3% | +$322 | ﹤0.01% | 7486 |
|
|
2014
Q4 | $11K | Buy |
+195
| New | +$9.29K | ﹤0.01% | 8304 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
